<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M520</article-id>
      <article-id pub-id-type="publisher-id">molbank-2006-M520</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Synthesis and Detailed Spectroscopic Characterization of Two Novel <italic>N</italic>-(3-Acetyl-2-thienyl)acetamides</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Eller</surname>
            <given-names>Gernot A.</given-names>
          </name>
          <xref rid="c1-molbank-2006-M520" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Holzer</surname>
            <given-names>Wolfgang</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2006-M520">Department of Drug Synthesis, Faculty of Life Sciences, University of Vienna, Althanstrasse 14, A-1090 Vienna, Austria Phone: +43-1-4277-55634, Email: <email>gernot.eller@univie.ac.at</email></aff>
	  <author-notes>
        <corresp id="c1-molbank-2006-M520"><label>*</label>Author to whom correspondence should be addressed</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>01</day>
        <month>12</month>
        <year>2006</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>12</month>
        <year>2006</year>
      </pub-date>
      <volume>2006</volume>
      <issue>6</issue>
      <elocation-id>M520</elocation-id>
      <history>
        <date date-type="received">
          <day>01</day>
          <month>09</month>
          <year>2006</year>
        </date>
        <date date-type="accepted">
          <day>20</day>
          <month>10</month>
          <year>2006</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2006 MDPI. All rights reserved.</copyright-statement>
        <copyright-year>2006</copyright-year>
      </permissions>
      <abstract>
        <p>The title compounds &#x2013; <italic>N</italic>-(3-acetyl-2-thienyl)-2-bromoacetamide and <italic>N</italic>-(3-acetyl-2-thienyl)-2-phthalimidoacetamide &#x2013; were synthesized in one step from 3-acetylthiophen-2-amine and the corresponding acetyl halogenides. Detailed spectroscopic data (<sup>1</sup>H NMR, <sup>13</sup>C NMR, <sup>15</sup>N NMR, MS, IR) for these compounds are presented.</p>
      </abstract>
      <kwd-group>
        <kwd><italic>N</italic>-acylations</kwd>
        <kwd>3-acetylthiophen-2-amine</kwd>
        <kwd>NMR spectroscopy</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
     <p>Recently, we have investigated a modified Gewald reaction [<xref ref-type="bibr" rid="B1-molbank-2006-M520">1</xref>] for the preparation of 3-acetyl-2-aminothiophenes [<xref ref-type="bibr" rid="B2-molbank-2006-M520">2</xref>]. We here report the synthesis of two acetamides derived from 3-acetylthiophen-2-amine (<bold>1</bold>) (<xref ref-type="scheme" rid="molbank-2006-M520-sch001">Scheme 1</xref>). These molecules are expected to be versatile intermediates for advanced investigations regarding the chemistry of 3-acetylthiophenes of type <bold>1</bold>.</p>
    <sec>
      <title><italic>N</italic>-(3-Acetyl-2-thienyl)-2-bromoacetamide (3a):</title>
      <p>Under stirring at room temperature, to 4.23 g (30 mmol) thiophenamine <bold>1 [<xref ref-type="bibr" rid="B2-molbank-2006-M520">2</xref>]</bold> in 70 mL of dry 1,4-dioxane were added dropwise 6.06 g (30 mmol) of bromoacetyl bromide (<bold>2a</bold>) in 20 mL of 1,4-dioxane. After 3 h the reaction mixture was poured into ice-cold H<sub>2</sub>O (ca. 300 mL), the resulting precipitate was filtered off, washed with H<sub>2</sub>O, and dried under reduced pressure to afford pure <bold>3a</bold> (4.72 g, 60%) as a beige powder.</p>
      <p>The compound slowly decomposes in DMSO- or MeOH-solution.</p>
	  <p>Melting point: 96&#x2013;97&#xB0;C.</p>
      <p>IR (KBr) [<xref ref-type="bibr" rid="B3-molbank-2006-M520">3</xref>]: 1660, 1640 cm<sup>&#x2013;1</sup>.</p>
      <p><sup>1</sup>H NMR (300 MHz, DMSO-<italic>d</italic><sub>6</sub>) [<xref ref-type="bibr" rid="B4-molbank-2006-M520">4</xref>]: &#x3B4; (ppm) 12.18 (s, 1H, NH), 7.43 (d, <sup>3</sup><italic>J</italic>(H4,H5) = 5.8 Hz, 1H, H4), 7.06 (d, <sup>3</sup><italic>J</italic>(H4,H5) = 5.8 Hz, 1H, H5), 4.43 (s, 2H, CH<sub>2</sub>), 2.52 (s, 3H, CH<sub>3</sub>).</p>
      <p><sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) [<xref ref-type="bibr" rid="B5-molbank-2006-M520">5</xref>]: &#x3B4; (ppm) 12.66 (s, 1H, NH), 7.23 (d, <sup>3</sup><italic>J</italic>(H4,H5) = 5.8 Hz, 1H, H4), 6.81 (d, <sup>3</sup><italic>J</italic>(H4,H5) = 5.8 Hz, 1H, H5), 4.09 (s, 2H, CH<sub>2</sub>), 2.55 (s, 3H, CH<sub>3</sub>).</p>
      <p><sup>13</sup>C NMR (75 MHz, DMSO-<italic>d</italic><sub>6</sub>) [<xref ref-type="bibr" rid="B4-molbank-2006-M520">4</xref>]: &#x3B4; (ppm) 195.8 (COCH<sub>3</sub>), 164.6 (NCO, <sup>2</sup><italic>J</italic>(NCO,CH<sub>2</sub>) = 4.3 Hz, <sup>2</sup><italic>J</italic>(NCO,NH) = 4.3 Hz), 147.0 (C2), 125.2 (C4, <sup>1</sup><italic>J</italic> = 170.2 Hz, <sup>2</sup><italic>J</italic>(C4,H5) = 4.2 Hz), 121.8 (C3), 117.1 (C5, <sup>1</sup><italic>J</italic> = 189.3 Hz, <sup>2</sup><italic>J</italic>(C5,H4) = 6.0 Hz), 29.0 (CH<sub>2</sub>, <sup>1</sup><italic>J</italic> = 155.6 Hz), 28.8 (CH<sub>3</sub>, <sup>1</sup><italic>J</italic> = 127.7 Hz).</p>
      <p><sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) [<xref ref-type="bibr" rid="B5-molbank-2006-M520">5</xref>]: &#x3B4; (ppm) 196.0 (COCH<sub>3</sub>, <sup>2</sup><italic>J</italic>(COCH<sub>3</sub>,CH<sub>3</sub>) = 5.9 Hz, <sup>3</sup><italic>J</italic>(CO,H4) = 0.9 Hz), 164.1 (NCO, <sup>2</sup><italic>J</italic>(NCO,CH<sub>2</sub>) = 4.5 Hz), 148.3 (C2, <sup>2</sup><italic>J</italic>(C2,NH) = 2.1 Hz, <sup>3</sup><italic>J</italic>(C2,H4) = 10.0 Hz, <sup>3</sup><italic>J</italic>(C2,H5) = 7.6 Hz), 124.4 (C4, <sup>1</sup><italic>J</italic> = 168.8 Hz, <sup>2</sup><italic>J</italic>(C4,H5) = 3.6 Hz), 122.0 (C3, <sup>2</sup><italic>J</italic>(C3,H4) = 5.8 Hz, <sup>3</sup><italic>J</italic>(C3,H5) = 9.1 Hz), <sup>3</sup><italic>J</italic>(C3,CH<sub>3</sub>) = 1.3 Hz), 116.9 (C5, <sup>1</sup><italic>J</italic> = 187.7 Hz, <sup>2</sup><italic>J</italic>(C5,H4) = 5.0 Hz), 28.7 (CH<sub>3</sub>, <sup>1</sup><italic>J</italic> = 127.9 Hz), 27.9 (CH<sub>2</sub>, <sup>1</sup><italic>J</italic> = 153.9 Hz).</p>
      <p><sup>15</sup>N NMR (50 MHz, CDCl<sub>3</sub>) [<xref ref-type="bibr" rid="B6-molbank-2006-M520">6</xref>]: &#x3B4; (ppm) &#x2013;248.9 (NH).</p>
      <p>MS (m/z, %) [<xref ref-type="bibr" rid="B7-molbank-2006-M520">7</xref>]: 263 (M<sup>+</sup>, 27), 261 (M<sup>+</sup>, 25), 141 (100), 126 (75), 43 (59).</p>
      <p>Elemental Analysis: Calculated for C<sub>8</sub>H<sub>8</sub>BrNO<sub>2</sub>S (262.12) &#xB7; 0.1 H<sub>2</sub>O: C, 36.41%; H, 3.13%; N, 5.31%.</p>
      <p>Found: C, 36.15%; H, 2.92%; N, 5.03%.</p>
    </sec>
    <sec>
      <title><italic>N</italic>-(3-Acetyl-2-thienyl)-2-(1,3-dioxo-1,3-dihydro-2<italic>H</italic>-isoindol-2-yl)acetamide (3b):</title>
      <p>At room temperature, to 2.12 g (15 mmol) of thiophenamine <bold>1 [<xref ref-type="bibr" rid="B2-molbank-2006-M520">2</xref>]</bold> in 20 mL of dry 1,4-dioxane were added dropwise 3.35 g (15 mmol) of phthalimidoacetyl chloride (<bold>2b</bold>) [<xref ref-type="bibr" rid="B8-molbank-2006-M520">8</xref>] in 20 mL of 1,4-dioxane. The reaction mixture was stirred overnight and then poured into H<sub>2</sub>O (ca. 100 mL). Upon neutralization with solid NaHCO3 a yellowish precipitate was formed which was filtered off, washed with H<sub>2</sub>O, and dried under reduced pressure to afford pure <bold>3b</bold> (4.33 g, 88%) as a yellowish powder.</p>
      <p>Melting point: 208&#x2013;212 &#xB0;C.</p>
      <p>IR (KBr) [<xref ref-type="bibr" rid="B3-molbank-2006-M520">3</xref>]: 1773, 1719, 1693, 1635 cm<sup>&#x2013;1</sup>.</p>
      <p><sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) [<xref ref-type="bibr" rid="B5-molbank-2006-M520">5</xref>]: &#x3B4; (ppm) 12.25 (s, 1H, NH), 7.91 (m, 2H, Phth-H3,6), 7.76 (m, 2H, Phth-H4,5), 7.17 (d, <sup>3</sup><italic>J</italic>(Th-H4,Th-H5) = 5.8 Hz, 1H, Th-H4), 6.75 (d, <sup>3</sup><italic>J</italic>(Th-H5,Th-H4) = 5.8 Hz, 1H, Th-H5), 4.65 (s, 2H, CH<sub>2</sub>), 2.49 (s, 3H, CH<sub>3</sub>).</p>
      <p><sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) [<xref ref-type="bibr" rid="B5-molbank-2006-M520">5</xref>]: &#x3B4; (ppm) 196.1 (COCH<sub>3</sub>), 167.4 (Phth-CO), 164.1 (HNCO), 148.5 (Th-C2), 134.4 (Phth-C4,5), 131.9 (Phth-C1,2), 124.2 (Th-C4), 123.8 (Phth-C3,6), 121.5 (Th-C3), 116.6 (Th-C5), 40.7 (CH<sub>2</sub>), 28.6 (CH<sub>3</sub>).</p>
      <p><sup>15</sup>N NMR (50 MHz, CDCl<sub>3</sub>) [<xref ref-type="bibr" rid="B6-molbank-2006-M520">6</xref>]: &#x3B4; (ppm) &#x2013;228.8 (NCH<sub>2</sub>), &#x2013;252.7 (NH).</p>
      <p>MS (m/z, %) [<xref ref-type="bibr" rid="B7-molbank-2006-M520">7</xref>]: 328 (M<sup>+</sup>, 17), 168 (17), 160 (100), 141 (27).</p>
      <p>Elemental Analysis: Calculated for C<sub>16</sub>H<sub>12</sub>N<sub>2</sub>O<sub>4</sub>S (328.34) &#xB7; 0.1 H<sub>2</sub>O: C, 58.21%; H, 3.72%; N, 8.49%.</p>
      <p>Found: C, 57.86%; H, 3.87%; N, 8.40%.</p>
    </sec>
  </body>
  <back>
   <app-group>
    <app id="app1-molbank-2006-M520">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2006-M520-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2006-M520-s001-mod.mol">
   <label>Supplementary File 1</label>
</supplementary-material>
        <supplementary-material id="molbank-2006-M520-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2006-M520-s001.mol">
   <label>Supplementary File 2</label>
</supplementary-material>
 <supplementary-material id="molbank-2006-M520-s003" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2006-M520-s002-mod.mol">
   <label>Supplementary File 3</label>
</supplementary-material>
        <supplementary-material id="molbank-2006-M520-s004" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2006-M520-s002.mol">
   <label>Supplementary File 4</label>
</supplementary-material>
    </app>
	</app-group>
	<ref-list>
      <title>References and Notes</title>
      <ref id="B1-molbank-2006-M520">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gewald</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <source>Chem. Ber.</source>
          <year>1965</year>
          <volume>98</volume>
          <fpage>3571</fpage>
          <lpage>3577</lpage>
        </citation>
      </ref>
      <ref id="B2-molbank-2006-M520">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eller</surname>
              <given-names>G. A.</given-names>
            </name>
            <name>
              <surname>Holzer</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <source>Molecules</source>
          <year>2006</year>
          <volume>11</volume>
          <fpage>371</fpage>
          <lpage>376</lpage>
          <pub-id pub-id-type="pmid">17962769</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2006-M520">
        <label>3.</label>
        <note>
          <p>The spectrum was obtained on a Perkin-Elmer FTIR 1605 spectrophotometer.</p>
        </note>
      </ref>
      <ref id="B4-molbank-2006-M520">
        <label>4.</label>
       <note>
          <p>The spectrum was obtained on a Varian UnityPlus 300 spectrometer (299.95 MHz for <sup>1</sup>H, 75.43 MHz for <sup>13</sup>C) at 28 &#xB0;C. The center of the solvent signal was used as an internal standard which was related to TMS with &#x3B4; 2.49 ppm (<sup>1</sup>H NMR) and &#x3B4; 39.5 ppm (<sup>13</sup>C NMR).</p>
         </note>
      </ref>
      <ref id="B5-molbank-2006-M520">
        <label>5.</label>
       <note>
          <p>The spectrum was obtained on a Bruker Avance 500 spectrometer (500.13 MHz for <sup>1</sup>H, 125.77 MHz for <sup>13</sup>C) at 294 K. The center of the solvent signal was used as an internal standard which was related to TMS with &#x3B4; 7.26 ppm (<sup>1</sup>H NMR) and &#x3B4; 77.0 ppm (<sup>13</sup>C NMR).</p>
        </note>
      </ref>
      <ref id="B6-molbank-2006-M520">
        <label>6.</label>
        <note>
          <p>The spectrum was obtained on a Bruker Avance 500 spectrometer (50.68 MHz for <sup>15</sup>N) and was referenced against neat, external nitromethane (coaxial capillary).</p>
         </note>
      </ref>
      <ref id="B7-molbank-2006-M520">
        <label>7.</label>
        <note>
          <p>The spectrum was obtained on a Shimadzu QP 1000 instrument (EI, 70eV).</p>
        </note>
      </ref>
      <ref id="B8-molbank-2006-M520">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Usifoh</surname>
              <given-names>C. O.</given-names>
            </name>
            <name>
              <surname>Lambert</surname>
              <given-names>D. M.</given-names>
            </name>
            <name>
              <surname>Wouters</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Scriba</surname>
              <given-names>G. K. E.</given-names>
            </name>
          </person-group>
          <source>Arch. Pharm. (Weinheim, Ger.)</source>
          <year>2001</year>
          <volume>334</volume>
          <fpage>323</fpage>
          <lpage>331</lpage>
        </citation>
      </ref>
    </ref-list>
    <sec sec-type="display-objects">
      <title>Scheme</title>
      <fig id="molbank-2006-M520-sch001" position="float">
        <object-id pub-id-type="pii">molbank-2006-M520-sch001_Scheme 1</object-id>
        <label>Scheme 1</label>
        <caption>
          <p>Preparation of the title compounds <bold>3a and 3b</bold></p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2006-M520-sch001.tif"/>
      </fig>
    </sec>
  </back>
</article>
